post weak result meaning cut full year guidanc
reimburs head wind sluggish retail volum challeng
uk oper environ continu weigh sever mitig effort
underway includ sizabl cost save program expect
industri challeng meaning abat near/intermedi term
think effort drive increas effici re-acceler growth take
time maintain hold rate cut estim
reduc price target ep
tough compani report soft result industri head wind
weak result prompt cut full year guidanc roughli flat ep
growth previou expect cut tie expect
on-going pharmaci margin pressur reimburs shift specialti
challeng market condit sever mitig initi
underway see fep specialti contract annual
view pharmaci margin pressur unlik abat near term think
industri challeng like continu
review continu progress manag expect complet
end april base find thu far compani increas
anticip annual cost save expect
realiz program encompass number target area
includ reorgan leadership team provid delin
develop deliveri focus manag strateg
partnership digit busi retail side continu
concentr effort high-margin product health/beauti well
area focu increas innov market also expect
on-going invest new exist partnership compani look
expand in-stor offer particularli healthcare/wel space
disappoint result revenu came modestli
slight miss vs strhe
wholesal vs strhe segment in-lin perform
pharmaci usa top line coupl lower expect
oi margin vs strhe improv sg
off-set reimburs pressur gener brand inflat shift specialti
tr target
rite aid integr cost nr invest associ new cost
manag program drive oper incom vs strhe adjust
script volum came lower volum revenu per script provid
off-set driven continu shift toward specialti compar retail sale fell yoy tie
weak cold flu season de-emphasi tobacco product lower season sale lastli despit
lower tax rate share count adjust ep eleven cent estim
soft cut estim cffo came well
estim legal settlement payout advers work capit chang relat
increas cash tax weigh addit compani repurchas share bring
ytd total declar quarterli dividend per share cash flow
trend impact number temporari item given expect upcom invest
oper head wind view improv gener key revis full
year adjust ep estim reflect updat guidanc continu head wind
respect
retail pharmaci wholesal detail retail pharmaci revenu
came currenc headwind challeng uk oper
fell ss retail sale pharmaci wholesal revenu
slightli driven unfavor currenc translat cc basi sale increas
tie strong emerg market uk result
page
revenu
revenu
revenu
net incom
non-gaap add back tax
adjust net incom
page
inc global leader pharmaceut servic industri
store sizabl wholesale/distribut network countri compani
largest retail pharmaci unit state retail pharmaci usa divis gener
total compani revenu remain sale come retail
intern pharmaci wholesal
bullish underli trend pharmaceut servic expect sever tailwind
age popul util growth drive on-going growth sector forese futur
believ recent format sever strateg partnership lh demonstr valu
compani scale/cap provid near term volum tailwind
reason optim challeng exist retail pharmaci busi continu see margin
pressur tie sever factor rate reimburs pressur payer contract
valuat risk
hold rate price target base stock trade adjust
cash ep slight premium current multipl upbeat underli trend
pharmaceut servic view compani scale key differenti like compani
free cash flow gener view risk/reward balanc given us pharmaci margin pressur
like linger difficult retail environ upsid risk price target includ better
synergi captur stronger core trend dissip pbm margin pressur aggress capit
deploy downsid risk includ issu integr increas price pressur addit
david macdonald herebi certifi view express research report accur reflect
person view subject compani secur also certifi
receiv direct indirect compens exchang express
specif recommend report
